Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Katherine L. Ender"'
Autor:
Delphine S Taylor, Julie S. Glickstein, Boyd F. Richards, Hetty Cunningham, Urmi A. Desai, Usha S Krishnan, Katherine L Ender, Rita Charon, Dorene F. Balmer
Publikováno v:
Academic medicine : journal of the Association of American Medical CollegesReferences cited only in Supplemental Digital Appendix 1. 96(8)
Purpose To investigate students' experience (over time) with meta-reflection writing exercises, called Signature Reflections. These exercises were used to strengthen reflective capacity, as part of a 4-year reflective writing portfolio curriculum tha
Autor:
Nancy S Green, Katherine L Ender, Farzana Pashankar, Catherine Driscoll, Patricia J Giardina, Craig A Mullen, Lorraine N Clark, Deepa Manwani, Jennifer Crotty, Sergey Kisselev, Kathleen A Neville, Carolyn Hoppe, Sandra Barral
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55709 (2013)
Fetal hemoglobin level is a heritable complex trait that strongly correlates swith the clinical severity of sickle cell disease. Only few genetic loci have been identified as robustly associated with fetal hemoglobin in patients with sickle cell dise
Externí odkaz:
https://doaj.org/article/b92ea4c772dc4035bd0462f3b0f400f6
Autor:
Mary Tresgallo, Jennifer Krajewski, John Babineau, Katherine L. Ender, John M. Saroyan, Anupam Kharbanda, William S. Schechter
Publikováno v:
Pediatric Blood & Cancer. 61:693-696
Background The most common, debilitating morbidity of sickle cell disease (SCD) is vaso-occlusive crisis (VOC) pain. Although guidelines exist for its management, they are generally not well-followed, and research in other pediatric diseases has show
Publikováno v:
Pediatric Hematology and Oncology. 33:134-135
ARTICLE HISTORY Received 31 August 2015; accepted 28 January 2016.Sickle cell disease, the most common inherited hematologic disorder, is estimated to affect 90,000–100,000 Americans [1, 2]. Sickle...
Autor:
Genia B. Billote, Robert H. DeBellis, Gary M. Brittenham, Katherine L. Ender, Bernard F. Erlanger
Publikováno v:
Pediatric Blood & Cancer. 56:843-845
To assess safety and tolerability, we administered valacyclovir, an oral anti-viral medication that inhibits erythrocyte sickling in vitro, to 14 subjects with sickle-cell anemia for 1 week at a standard dose of 1,000 mg every 8 hr. No clinically sig
Autor:
Katherine L, Ender, Jennifer A, Krajewski, John, Babineau, Mary, Tresgallo, William, Schechter, John M, Saroyan, Anupam, Kharbanda
Publikováno v:
Pediatric bloodcancer. 61(4)
The most common, debilitating morbidity of sickle cell disease (SCD) is vaso-occlusive crisis (VOC) pain. Although guidelines exist for its management, they are generally not well-followed, and research in other pediatric diseases has shown that clin
Autor:
Deepa Manwani, Farzana Pashankar, Lorraine N. Clark, Patricia J. Giardina, Carolyn Hoppe, Jennifer Crotty, Kathleen A. Neville, Sergey Kisselev, Nancy S. Green, Craig A. Mullen, Catherine Driscoll, Katherine L. Ender, Sandra Barral
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55709 (2013)
PLoS ONE
PLoS ONE
Background Fetal hemoglobin level is a heritable complex trait that strongly correlates swith the clinical severity of sickle cell disease. Only few genetic loci have been identified as robustly associated with fetal hemoglobin in patients with sickl
Autor:
Margaret T. Lee, Jennifer Crotty, Nancy S. Green, Sujit Sheth, Maureen Licursi, Katherine L. Ender, Sandra Barral
Publikováno v:
Journal of pediatric hematology/oncology. 33(7)
The degree of fetal hemoglobin (HbF) expression is a major determinant of phenotypic severity of sickle cell disease (SCD). Genetic regulation of HbF production is complex and can vary among ethnic groups. The pediatric sickle cell population at our
Autor:
Katherine L, Ender, Robert H, DeBellis, Bernard F, Erlanger, Genia B, Billote, Gary M, Brittenham
Publikováno v:
Pediatric bloodcancer. 56(5)
To assess safety and tolerability, we administered valacyclovir, an oral anti-viral medication that inhibits erythrocyte sickling in vitro, to 14 subjects with sickle-cell anemia for 1 week at a standard dose of 1,000 mg every 8 hr. No clinically sig
Autor:
Patricia J. Giardina, Lorraine N. Clark, Sandra Barral, Jennifer Crotty, Catherine Driscoll, Katherine L. Ender, Carolyn Hoppe, Craig A. Mullen, Farzana Pashankar, Nancy S. Green, Mara Burney
Publikováno v:
Blood. 116:2641-2641
Abstract 2641 Abstract: Only few genes appear to strongly regulate HbF levels in adults with sickle cell disease (SCD). We aim to: (1) Extend these observations to children with SCD, who likely have better preserved marrow capacity; (2) Assess whethe